Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Hypertension

Free Subscription Articles published in Circulation Retrieve available abstracts of 76 articles: HTML format

Single Articles

January 2026
1. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
   Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
   Circulation. 2026 Jan 28. doi: 10.1161/CIRCULATIONAHA.125.079067.
   PubMed     Abstract available
   
   
   
2. TADA A, Fayyaz AU, Reddy YNV, Redfield MM, et al
   Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.
   Circulation. 2026;153:285-289.
   PubMed    
   
   
   
3. COHEN JB, Jones DW, Flack JM
   From Race-Based to Equity-Informed Antihypertensive Medication Selection: Rationale for the 2025 AHA/ACC Guideline Change.
   Circulation. 2026;153:137-139.
   PubMed    
   
   
   December 2025
4. LI F, Poudel B, Andrade-Silva M, Wu J, et al
   Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage.
   Circulation. 2025 Dec 11:10.1161/CIRCULATIONAHA.124.071351.
   PubMed     Abstract available
   
   
   October 2025
5. CAI A, Bayes-Genis A, Ryan J, Feng Y, et al
   Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial.
   Circulation. 2025 Oct 22. doi: 10.1161/CIRCULATIONAHA.125.076263.
   PubMed     Abstract available
   
   
   
6. LIU J, Zhang L, Chen Z
   Letter by Liu et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
   Circulation. 2025;152:e285-e286.
   PubMed    
   
   
   
7. HUANG J
   Letter by Huang Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
   Circulation. 2025;152:e289-e290.
   PubMed    
   
   
   
8. JOHNSTON A, Edwards JD, Coutinho T
   Response by Johnston et al to Letters Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
   Circulation. 2025;152:e291-e292.
   PubMed    
   
   
   
9. FAUCHIER L, Lochon L, Lip GYH
   Letter by Fauchier et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
   Circulation. 2025;152:e287-e288.
   PubMed    
   
   
   
10. KORNELIUS E
    Letter by Kornelius Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e284.
    PubMed    
    
    
    September 2025
11. JONES DW, Ferdinand KC, Taler SJ, Johnson HM, et al
    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Commit
    Circulation. 2025;152:e114-e218.
    PubMed     Abstract available
    
    
    August 2025
12. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    PubMed     Abstract available
    
    
    June 2025
13. ZHANG F, Zhong Y
    Letter by Zhang and Zhong Regarding Article, "Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis".
    Circulation. 2025;151:e1072.
    PubMed    
    
    
    
14. VUKADINOVIC D, Lauder L, Mahfoud F
    Response by Vukadinovic et al to Letter Regarding Article, "Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis".
    Circulation. 2025;151:e1073-e1074.
    PubMed    
    
    
    
15. WANG J, Yuan Z, Yu N, Jiao Q, et al
    Inactivation of RhoA for Hypertension Treatment Through the TRPV4-RhoA-RhoGDI1 Axis.
    Circulation. 2025 Jun 16. doi: 10.1161/CIRCULATIONAHA.124.071884.
    PubMed     Abstract available
    
    
    
16. KIM HK, Fukazawa A, Smith SA, Mizuno M, et al
    High Dietary Phosphate Intake Induces Hypertension and Sympathetic Overactivation Through Central Fibroblast Growth Factor Receptor Signaling.
    Circulation. 2025 Jun 5. doi: 10.1161/CIRCULATIONAHA.124.071605.
    PubMed     Abstract available
    
    
    April 2025
17. YU Q, Tai YY, Tang Y, Zhao J, et al
    Correction to: BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Circulation. 2025;151:e967.
    PubMed    
    
    
    
18. AGRAWAL V, Hemnes AR
    Integrin Targeting Therapies in Pulmonary Arterial Hypertension: A Roadmap for Traversing the Translational Valley of Death?
    Circulation. 2025;151:1184-1186.
    PubMed    
    
    
    
19. SINGH R, Kulthinee S, Nasci VL, Akwo EA, et al
    G-Protein-Coupled Estrogen Receptor 1 and Pregnancy Confer Protection Against Hypertension in Older Females.
    Circulation. 2025;151:1126-1129.
    PubMed    
    
    
    
20. HONG J, Medzikovic L, Sun W, Wong B, et al
    Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2025;151:e921.
    PubMed    
    
    
    
21. CAO N, Lan C, Chen C, Xu Z, et al
    Correction to: Prenatal Lipopolysaccharides Exposure Induces Transgenerational Inheritance of Hypertension.
    Circulation. 2025;151:e866.
    PubMed    
    
    
    March 2025
22. NIIRANEN TJ, Schnabel RB, Schutte AE, Biton Y, et al
    Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration.
    Circulation. 2025;151:863-877.
    PubMed     Abstract available
    
    
    
23. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2025;151:e763.
    PubMed    
    
    
    
24. VONGPATANASIN W, Turcu AF
    The Journey of Resistant Hypertension: From the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure to American Heart Association/American College of Cardiology Guidelines.
    Circulation. 2025;151:653-655.
    PubMed    
    
    
    
25. DAI H, Lu X, Zhou X
    Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction".
    Circulation. 2025;151:e686.
    PubMed    
    
    
    February 2025
26. YU AYX, Auger N, Fu L, Chu A, et al
    Population-Level Screening for Diabetes and Dyslipidemia After Pregnancies Complicated by Hypertension or Diabetes.
    Circulation. 2025;151:508-510.
    PubMed    
    
    
    
27. COUNTOURIS M, Mahmoud Z, Cohen JB, Crousillat D, et al
    Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care.
    Circulation. 2025;151:490-507.
    PubMed     Abstract available
    
    
    
28. JOHNSTON A, Petrcich W, Smith GN, Fell DB, et al
    Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study.
    Circulation. 2025 Feb 11. doi: 10.1161/CIRCULATIONAHA.124.072418.
    PubMed     Abstract available
    
    
    
29. KRESS TC, Barris CT, Kovacs L, Khakina BN, et al
    CD4(+) T Cells Expressing Viral Proteins Induce HIV-Associated Endothelial Dysfunction and Hypertension Through Interleukin 1alpha-Mediated Increases in Endothelial NADPH Oxidase 1.
    Circulation. 2025 Feb 5. doi: 10.1161/CIRCULATIONAHA.124.070538.
    PubMed     Abstract available
    
    
    January 2025
30. HOEPER MM, Haughie S, Hassan T, Vogt S, et al
    Response by Hoeper et al to Letter Regarding Article, "Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults with Pulmonary Arterial Hypertension".
    Circulation. 2025;151:e32.
    PubMed    
    
    
    
31. YAN P, Zhang M, Cao Y
    Letter by Yan et al Regarding Article, "Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension".
    Circulation. 2025;151:e31.
    PubMed    
    
    
    
32. LEMAY SE, Montesinos MS, Grobs Y, Yokokawa T, et al
    Exploring Integrin alpha5beta1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.
    Circulation. 2025 Jan 20. doi: 10.1161/CIRCULATIONAHA.124.070693.
    PubMed     Abstract available
    
    
    December 2024
33. LAFFIN LJ
    Future of Antihypertensive Therapies.
    Circulation. 2024;150:1987-1989.
    PubMed    
    
    
    November 2024
34. ZHANG M, Pan X, Zhu X
    Letter by Zhang et al Regarding Article, "Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era".
    Circulation. 2024;150:e467.
    PubMed    
    
    
    
35. MCLAUGHLIN VV, Humbert M
    Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic Interventions.
    Circulation. 2024;150:1653-1655.
    PubMed    
    
    
    October 2024
36. BARONE GIBBS B, Perera S, Huber KA, Paley JL, et al
    Effects of Sedentary Behavior Reduction on Blood Pressure in Desk Workers: Results From the RESET-BP Randomized Clinical Trial.
    Circulation. 2024;150:1416-1427.
    PubMed     Abstract available
    
    
    
37. DELCROIX M, Pepke-Zaba J, D'Armini AM, Fadel E, et al
    Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.
    Circulation. 2024;150:1354-1365.
    PubMed     Abstract available
    
    
    
38. VUKADINOVIC D, Lauder L, Kandzari DE, Bhatt DL, et al
    Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis.
    Circulation. 2024 Oct 2. doi: 10.1161/CIRCULATIONAHA.124.069709.
    PubMed     Abstract available
    
    
    
39. GIANNOPOULOS AA, Gimelli A
    Unveiling the Hidden Layers of Hypertensive Heart Disease Through Quantitative PET Imaging.
    Circulation. 2024;150:1087-1089.
    PubMed    
    
    
    September 2024
40. JIANG X, Mahfoud F, Li W, Dong H, et al
    Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069215.
    PubMed     Abstract available
    
    
    August 2024
41. HONG J, Medzikovic L, Sun W, Wong B, et al
    Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069864.
    PubMed     Abstract available
    
    
    
42. XU X, Divakaran S, Weber BN, Hainer J, et al
    Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.067083.
    PubMed     Abstract available
    
    
    
43. ZHANG Z, Liu K, Chen X
    Letter by Zhang et al Regarding Article, "Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program".
    Circulation. 2024;150:e181-e182.
    PubMed    
    
    
    July 2024
44. LIU B, Yi D, Xia X, Ramirez K, et al
    General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2alpha/Notch4 Pathway.
    Circulation. 2024;150:414-417.
    PubMed    
    
    
    
45. COOPER LA, Marsteller JA, Carson KA, Dietz KB, et al
    Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial.
    Circulation. 2024;150:230-242.
    PubMed     Abstract available
    
    
    June 2024
46. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069340.
    PubMed     Abstract available
    
    
    
47. ZHANG Q, Yaoita N, Tabuchi A, Liu S, et al
    Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.124.068726.
    PubMed     Abstract available
    
    
    
48. 
    Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1412.
    PubMed    
    
    
    May 2024
49. SALAHUDDIN A, Harris IS, Sabanayagam A
    Double Whammy Complicating Management of Pulmonary Hypertension.
    Circulation. 2024;149:1770-1774.
    PubMed    
    
    
    
50. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    PubMed     Abstract available
    
    
    
51. HOEPER MM, Ewert R, Jansa P, Sirenko Y, et al
    Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.123.068107.
    PubMed     Abstract available
    
    
    
52. RUBIN LJ
    Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?
    Circulation. 2024;149:1565-1567.
    PubMed    
    
    
    
53. HARING B, Andrews CA, Hovey K, Shadyab AH, et al
    Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative.
    Circulation. 2024;149:1568-1577.
    PubMed     Abstract available
    
    
    
54. TANG H, Gupta A, Morrisroe SA, Bao C, et al
    Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
    Circulation. 2024 May 2. doi: 10.1161/CIRCULATIONAHA.123.065304.
    PubMed     Abstract available
    
    
    April 2024
55. BORDAN Z, Batori R, Haigh S, Li X, et al
    PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.067095.
    PubMed     Abstract available
    
    
    
56. RAO RJ, Chan SY
    Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
    Circulation. 2024;149:1372-1374.
    PubMed    
    
    
    
57. GERHARDT F, Fiessler E, Olsson KM, Kayser MZ, et al
    Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821.
    PubMed     Abstract available
    
    
    
58. KANDZARI DE, Weber MA, Pathak A, Zidar JP, et al
    Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results from the TARGET BP I Randomized Clinical Trial.
    Circulation. 2024 Apr 8. doi: 10.1161/CIRCULATIONAHA.124.069291.
    PubMed     Abstract available
    
    
    
59. SHEN H, Gao Y, Ge D, Tan M, et al
    BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430.
    PubMed     Abstract available
    
    
    March 2024
60. PETER JG, Ntusi NAB, Ntsekhe M
    Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?
    Circulation. 2024;149:804-806.
    PubMed    
    
    
    
61. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    PubMed     Abstract available
    
    
    February 2024
62. REDING KW, Jordan JH
    Multimodal Imaging Evidence for Optimized Blood Pressure Control Following Hypertensive Pregnancy: Mechanistic Insights Into Beneficial Cardiac Remodeling From the POP-HT Trial.
    Circulation. 2024;149:542-544.
    PubMed    
    
    
    
63. PITT B, Williams GH
    Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?
    Circulation. 2024;149:414-416.
    PubMed    
    
    
    
64. LUO Y, Qi X, Zhang Z, Zhang J, et al
    Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
    Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
    PubMed     Abstract available
    
    
    January 2024
65. BIAN JS, Chen J, Zhang J, Tan J, et al
    ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
    Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
    PubMed     Abstract available
    
    
    December 2023
66. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    PubMed     Abstract available
    
    
    
67. REAY WR, Clarke E, Eslick S, Riveros C, et al
    Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension.
    Circulation. 2023 Dec 22. doi: 10.1161/CIRCULATIONAHA.123.065394.
    PubMed     Abstract available
    
    
    
68. RASMUSSEN SB, Jeppesen KK, Kjaergaard J, Hassager C, et al
    Blood Pressure and Oxygen Targets on Kidney Injury After Cardiac Arrest.
    Circulation. 2023;148:1860-1869.
    PubMed     Abstract available
    
    
    November 2023
69. HUNDEMER GL, Agharazii M, Madore F, Vaidya A, et al
    Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066389.
    PubMed     Abstract available
    
    
    
70. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
    Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1825-1826.
    PubMed    
    
    
    
71. LI G, Chen H, Ren C
    Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1823-1824.
    PubMed    
    
    
    
72. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    PubMed    
    
    
    
73. KITT J, Krasner S, Barr L, Frost A, et al
    Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Sub-study.
    Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067597.
    PubMed     Abstract available
    
    
    October 2023
74. AZIZI M, Sharp ASP, Fisher NDL, Weber MA, et al
    Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months Following Medication Escalation: The RADIANCE Clinical Trial Program.
    Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.066941.
    PubMed     Abstract available
    
    
    
75. OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al
    Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254.
    PubMed     Abstract available
    
    
    September 2023
76. KUEHN BM
    Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
    Circulation. 2023;148:852-854.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.